Natco Total Revenue vs Short Term Debt Analysis

NATCOPHARM

1,415 39.60 2.88%

Natco Pharma financial indicator trend analysis is infinitely more than just investigating Natco Pharma Limited recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Natco Pharma Limited is a good investment. Please check the relationship between Natco Pharma Total Revenue and its Short Term Debt accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Natco Pharma Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

Total Revenue vs Short Term Debt

Total Revenue vs Short Term Debt Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Natco Pharma Limited Total Revenue account and Short Term Debt. At this time, the significance of the direction appears to have fragmental relationship.

The correlation between Natco Pharma's Total Revenue and Short Term Debt is 0.54. Overlapping area represents the amount of variation of Total Revenue that can explain the historical movement of Short Term Debt in the same time period over historical financial statements of Natco Pharma Limited, assuming nothing else is changed. The correlation between historical values of Natco Pharma's Total Revenue and Short Term Debt is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Revenue of Natco Pharma Limited are associated (or correlated) with its Short Term Debt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Short Term Debt has no effect on the direction of Total Revenue i.e., Natco Pharma's Total Revenue and Short Term Debt go up and down completely randomly.

Correlation Coefficient

0.54

Relationship Direction	Positive
Relationship Strength	Weak

View All Relationships

Total Revenue

Total revenue comprises all receipts Natco Pharma Limited generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Short Term Debt

Most indicators from Natco Pharma's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Natco Pharma Limited current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Natco Pharma Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

As of now, Natco Pharma's Selling General Administrative is increasing as compared to previous years. The Natco Pharma's current Discontinued Operations is estimated to increase to about 34.3 M, while Tax Provision is projected to decrease to under 1.6 B.

	2022	2023	2024 (projected)
Interest Expense	145M	192M	180.0M
Depreciation And Amortization	1.6B	1.9B	2.0B

Interest Expense Depreciation And Amortization

Natco Pharma fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Accounts Payable	Net Receivables	Good Will	Intangible Assets	Short Term Debt
Total Assets		0.44	0.34	0.92	1.0	0.98	0.25	0.98	0.49	0.99	0.54	0.96	0.79	0.95	-0.28	0.97	0.86	0.75	-0.06	0.99	0.75	0.68	0.94	0.3	0.8	0.68
Short Long Term Debt Total	0.44		-0.16	0.48	0.42	0.51	0.94	0.41	0.07	0.5	0.15	0.37	0.48	0.37	0.27	0.43	0.19	0.43	0.39	0.39	0.43	0.33	0.31	0.29	0.21	0.93
Other Current Liab	0.34	-0.16		0.55	0.32	0.26	-0.17	0.37	0.04	0.27	0.31	0.23	0.32	0.32	-0.02	0.31	0.45	0.04	0.12	0.37	0.31	-0.25	0.52	0.01	0.37	0.0
Total Current Liabilities	0.92	0.48	0.55		0.91	0.9	0.34	0.9	0.34	0.9	0.44	0.86	0.83	0.88	-0.15	0.87	0.8	0.67	0.09	0.92	0.8	0.52	0.94	0.23	0.72	0.69
Total Stockholder Equity	1.0	0.42	0.32	0.91		0.98	0.22	0.98	0.5	0.98	0.55	0.97	0.78	0.95	-0.3	0.97	0.85	0.76	-0.08	0.99	0.74	0.68	0.94	0.3	0.8	0.67
Property Plant And Equipment Net	0.98	0.51	0.26	0.9	0.98		0.32	0.94	0.48	1.0	0.41	0.92	0.87	0.88	-0.29	0.98	0.75	0.82	-0.08	0.95	0.82	0.68	0.87	0.24	0.7	0.74
Net Debt	0.25	0.94	-0.17	0.34	0.22	0.32		0.21	-0.29	0.3	-0.01	0.2	0.36	0.23	0.51	0.23	-0.02	0.27	0.59	0.21	0.32	0.19	0.14	0.04	-0.05	0.81
Retained Earnings	0.98	0.41	0.37	0.9	0.98	0.94	0.21		0.51	0.96	0.66	0.94	0.69	0.96	-0.29	0.93	0.91	0.64	-0.08	0.98	0.64	0.61	0.95	0.4	0.87	0.64
Cash	0.49	0.07	0.04	0.34	0.5	0.48	-0.29	0.51		0.51	0.43	0.45	0.28	0.37	-0.69	0.53	0.57	0.39	-0.61	0.47	0.24	0.36	0.46	0.66	0.71	0.24
Non Current Assets Total	0.99	0.5	0.27	0.9	0.98	1.0	0.3	0.96	0.51		0.47	0.92	0.84	0.9	-0.3	0.98	0.79	0.78	-0.09	0.96	0.79	0.66	0.89	0.31	0.76	0.73
Non Currrent Assets Other	0.54	0.15	0.31	0.44	0.55	0.41	-0.01	0.66	0.43	0.47		0.52	-0.03	0.61	0.0	0.46	0.75	-0.02	0.1	0.59	-0.06	0.11	0.62	0.52	0.77	0.26
Cash And Short Term Investments	0.96	0.37	0.23	0.86	0.97	0.92	0.2	0.94	0.45	0.92	0.52		0.71	0.98	-0.3	0.89	0.84	0.76	-0.1	0.98	0.66	0.78	0.92	0.23	0.75	0.62
Common Stock Shares Outstanding	0.79	0.48	0.32	0.83	0.78	0.87	0.36	0.69	0.28	0.84	-0.03	0.71		0.65	-0.24	0.84	0.46	0.88	-0.04	0.75	0.97	0.56	0.68	0.0	0.4	0.68
Short Term Investments	0.95	0.37	0.32	0.88	0.95	0.88	0.23	0.96	0.37	0.9	0.61	0.98	0.65		-0.21	0.86	0.88	0.66	0.0	0.98	0.61	0.71	0.95	0.25	0.78	0.6
Non Current Liabilities Total	-0.28	0.27	-0.02	-0.15	-0.3	-0.29	0.51	-0.29	-0.69	-0.3	0.0	-0.3	-0.24	-0.21		-0.29	-0.41	-0.29	0.97	-0.27	-0.22	-0.37	-0.28	-0.42	-0.48	0.14
Inventory	0.97	0.43	0.31	0.87	0.97	0.98	0.23	0.93	0.53	0.98	0.46	0.89	0.84	0.86	-0.29		0.75	0.79	-0.09	0.94	0.79	0.59	0.85	0.26	0.72	0.69
Other Current Assets	0.86	0.19	0.45	0.8	0.85	0.75	-0.02	0.91	0.57	0.79	0.75	0.84	0.46	0.88	-0.41	0.75		0.41	-0.23	0.89	0.44	0.52	0.93	0.55	0.96	0.38
Other Stockholder Equity	0.75	0.43	0.04	0.67	0.76	0.82	0.27	0.64	0.39	0.78	-0.02	0.76	0.88	0.66	-0.29	0.79	0.41		-0.13	0.72	0.85	0.76	0.61	-0.01	0.34	0.65
Total Liab	-0.06	0.39	0.12	0.09	-0.08	-0.08	0.59	-0.08	-0.61	-0.09	0.1	-0.1	-0.04	0.0	0.97	-0.09	-0.23	-0.13		-0.05	-0.03	-0.25	-0.06	-0.37	-0.31	0.3
Total Current Assets	0.99	0.39	0.37	0.92	0.99	0.95	0.21	0.98	0.47	0.96	0.59	0.98	0.75	0.98	-0.27	0.94	0.89	0.72	-0.05		0.7	0.67	0.97	0.29	0.81	0.64
Common Stock	0.75	0.43	0.31	0.8	0.74	0.82	0.32	0.64	0.24	0.79	-0.06	0.66	0.97	0.61	-0.22	0.79	0.44	0.85	-0.03	0.7		0.56	0.64	-0.02	0.37	0.6
Accounts Payable	0.68	0.33	-0.25	0.52	0.68	0.68	0.19	0.61	0.36	0.66	0.11	0.78	0.56	0.71	-0.37	0.59	0.52	0.76	-0.25	0.67	0.56		0.59	0.13	0.43	0.48
Net Receivables	0.94	0.31	0.52	0.94	0.94	0.87	0.14	0.95	0.46	0.89	0.62	0.92	0.68	0.95	-0.28	0.85	0.93	0.61	-0.06	0.97	0.64	0.59		0.34	0.86	0.55
Good Will	0.3	0.29	0.01	0.23	0.3	0.24	0.04	0.4	0.66	0.31	0.52	0.23	0.0	0.25	-0.42	0.26	0.55	-0.01	-0.37	0.29	-0.02	0.13	0.34		0.72	0.23
Intangible Assets	0.8	0.21	0.37	0.72	0.8	0.7	-0.05	0.87	0.71	0.76	0.77	0.75	0.4	0.78	-0.48	0.72	0.96	0.34	-0.31	0.81	0.37	0.43	0.86	0.72		0.38
Short Term Debt	0.68	0.93	0.0	0.69	0.67	0.74	0.81	0.64	0.24	0.73	0.26	0.62	0.68	0.6	0.14	0.69	0.38	0.65	0.3	0.64	0.6	0.48	0.55	0.23	0.38

Click cells to compare fundamentals

Natco Pharma Account Relationship Matchups

Natco Pharma fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	45.9B	47.9B	51.1B	56.6B	69.1B	72.5B
Short Long Term Debt Total	3.3B	2.8B	4.3B	1.7B	3.9B	2.4B
Other Current Liab	844M	938M	360M	1.5B	3.2B	3.4B
Total Current Liabilities	6.9B	5.3B	7.1B	6.8B	9.7B	10.2B
Total Stockholder Equity	37.7B	41.2B	42.6B	48.7B	58.5B	61.5B
Property Plant And Equipment Net	20.9B	22.4B	23.1B	23.0B	24.4B	25.6B
Net Debt	3.1B	2.6B	3.2B	348M	3.2B	2.0B
Retained Earnings	22.4B	25.7B	26.7B	32.9B	44.7B	46.9B
Cash	198M	258M	1.1B	1.3B	704M	412.4M
Non Current Assets Total	22.6B	24.5B	26.1B	26.6B	28.8B	30.3B
Non Currrent Assets Other	(1M)	285M	469M	271M	955M	1.0B
Cash And Short Term Investments	9.0B	8.1B	7.6B	11.6B	13.9B	14.6B
Common Stock Shares Outstanding	182.5M	182.5M	182.4M	182.6M	179.5M	176.8M
Short Term Investments	8.8B	7.8B	6.5B	10.3B	17.1B	17.9B
Liabilities And Stockholders Equity	45.9B	47.9B	51.1B	56.6B	69.1B	72.5B
Non Current Liabilities Total	1.2B	1.4B	1.4B	(41.6B)	804M	844.2M
Inventory	5.6B	8.0B	7.6B	7.4B	7.9B	8.3B
Other Current Assets	1.7B	1.1B	2.4B	5.4B	6.5B	6.8B
Other Stockholder Equity	13.7B	13.9B	14.1B	14.1B	12.0B	7.1B
Total Liab	8.0B	6.7B	8.5B	(34.8B)	10.5B	11.1B
Total Current Assets	23.3B	23.4B	25.0B	30.0B	40.2B	42.2B
Accumulated Other Comprehensive Income	(5.5B)	1.3B	1.5B	1.4B	1.5B	1.6B
Accounts Payable	2.6B	1.5B	1.6B	2.6B	2.4B	1.3B
Net Receivables	5.5B	4.1B	6.2B	8.6B	11.9B	12.5B
Intangible Assets	88M	94M	822M	1.3B	1.4B	1.4B
Short Term Debt	3.3B	2.8B	4.2B	1.8B	3.8B	2.5B
Current Deferred Revenue	85M	13M	877M	1.1B	853M	923.4M
Other Liab	1.2B	1.4B	1.3B	994M	1.1B	834.9M
Net Tangible Assets	37.6B	41.1B	41.3B	46.9B	53.9B	30.4B
Other Assets	762M	486M	662M	271M	243.9M	451.6M
Short Long Term Debt	3.3B	2.8B	4.0B	1.7B	3.6B	2.6B
Property Plant Equipment	20.9B	22.4B	23.1B	23.0B	26.5B	17.5B
Capital Surpluse	13.7B	13.9B	14.1B	14.1B	16.2B	13.4B
Net Invested Capital	41.0B	41.2B	46.7B	50.4B	62.2B	49.1B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

TITAN	Titan Company Limited
U	Unity Software
PAYC	Paycom Soft

Other Information on Investing in Natco Stock

Balance Sheet is a snapshot of the financial position of Natco Pharma Limited at a specified time, usually calculated after every quarter, six months, or one year. Natco Pharma Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Natco Pharma and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Natco currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Natco Total Revenue vs Short Term Debt Analysis

Total Revenue vs Short Term Debt

Total Revenue vs Short Term Debt Correlation Analysis

Correlation Coefficient

Total Revenue

Short Term Debt

Natco Pharma fundamental ratios Correlations

Natco Pharma Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Natco Pharma fundamental ratios Accounts

Also Currently Popular

Other Information on Investing in Natco Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Non Current Assets Total	+ 1.0	Property Plant And Equipment Net
Non Current Assets Total	+ 0.99	Total Assets
Total Current Assets	+ 0.99	Total Assets
Total Current Assets	+ 0.99	Total Stockholder Equity
Property Plant And Equipment Net	+ 0.98	Total Assets

Non Current Liabilities Total	- 0.69	Cash
Total Liab	- 0.61	Cash
Intangible Assets	- 0.48	Non Current Liabilities Total
Good Will	- 0.42	Non Current Liabilities Total
Other Current Assets	- 0.41	Non Current Liabilities Total
Good Will	- 0.37	Total Liab